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Board Member Spotlight: 
 
Michael J. Goodheart, MD 
 
 
Dr. Michael Goodheart, Assistant 
Professor of Obstetrics and Gynecology 
in the Division of Gynecologic Oncology 
at the University of Iowa, joins us as a 
guest editor for this issue of 
Proceedings in 
Obstetrics and 
Gynecology, 
which is focused 
on topics related 
to gynecologic 
oncology. Here 
we provide a 
profile of Dr. 
Goodheart’s 
background that 
guided the path 
for his current 
clinical and 
research 
endeavors. 
 
A Louisiana 
native, Dr. 
Goodheart 
received a B.A. 
in Chemistry from North Carolina State 
University in 1990 and an M.D. from 
East Carolina University School of 
Medicine in 1995. It was during his 
second year of medical school that Dr. 
Goodheart made the pivotal decision to 
become a surgeon. According to Dr. 
Goodheart, on his way home one night 
he took his usual shortcut through the 
ER and happened to see a fellow 
medical student preparing a patient with 
a large pelvic mass for surgery. Dr. 
Goodheart stayed and observed the 
surgery from the initial administration of 
anesthesia to removing the mass and 
observing her 
wake up. In 
particular, Dr. 
Goodheart was 
in awe of the 
ability to see 
how one’s 
actions have 
immediate 
results, and soon 
after this 
experience he 
made the 
decision to 
pursue surgery. 
His interest in 
gynecologic 
oncology 
developed as an 
extension of his 
passion for 
surgery. In particular, he chose this field 
because of the opportunities to treat 
patients with complex medical problems 
that require surgery. Dr. Goodheart 
remained in the south for his residency 
in obstetrics and gynecology at 
Louisiana State University School of 
Medicine. He then made a transition to 
the Midwest in 2000 as a Fellow in the 
Gynecologic Oncology Division at the 
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University of Iowa, where he has 
remained and advanced in the ranks to 
Assistant Professor.  
 
As a fellow, Dr. Goodheart quickly 
realized that most treatments for 
gynecologic cancers (surgery, 
chemotherapy, radiation) are not 100% 
effective in eradicating the disease. “No 
matter how great a surgeon you are, 
there are things that can’t be fixed with a 
scalpel,” explained Dr. Goodheart. This 
realization guided the second major step 
in his career path: to conduct 
translational research that will identify 
new treatment modalities for patients 
with gynecologic cancers. This drive to 
improve patient outcomes spurred his 
collaboration with Dr. John Engelhardt, 
Professor and Head of Anatomy & Cell 
Biology at the University of Iowa, who 
has studied gland growth in the trachea. 
Most endometrial cancers are gland-
forming cancers, and Dr. Goodheart 
used this link to reach out to Dr. 
Engelhardt for mentorship. According to 
Dr. Goodheart, his relationship with Dr. 
Engelhardt was a major deciding factor 
in staying at the University of Iowa as 
faculty after his fellowship. In their 
ongoing collaboration, Dr. Engelhardt 
serves as a role model for Dr. 
Goodheart about how to be an excellent 
scientist and how to navigate his career 
through academic medicine. 
 
The research focus of Dr. Goodheart’s 
group is to unravel the role of the Wnt 
pathway in endometrial cancer. About 
20-40% of endometrial tumors exhibit 
dysregulation of this pathway. Dr. 
Goodheart’s group focuses on how Wnt 
pathway activation of lymphoid 
enhancer factor-1 (LEF-1) transcription 
contributes to the development of 
disease. The hope is that understanding 
the factors controlling LEF-1 
transcription will reveal new therapeutic 
options for patients whose endometrial 
tumors rely on this pathway. For this 
and other research projects, Dr. 
Goodheart maintains an active 
relationship with Dr. Englehardt and has 
forged a new working relationship with 
Dr. Adam Dupuy, Assistant Professor of 
Anatomy & Cell Biology, to study 
ovarian cancer, which is another major 
research focus of his laboratory.  
 
Dr. Goodheart’s initial studies with Dr. 
Engelhardt enabled him to apply for a 
physician-scientist grant. In 2007, he 
was awarded a Research Scientist 
Development Program Grant (K12) that 
provided him five years of research 
support. In addition to the financial 
benefits of receiving such a competitive 
source of funding, Dr. Goodheart cites 
this award as a particularly valuable 
achievement in his career. For him, 
receiving this grant from his peers 
validated that his ideas are worth 
pursuing.  
 
Written by Kristina W. Thiel 
Scientific Associate Editor 
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